Snowball logo
logo
6886

Jiangsu GDK Biotechnology Co Ltd

688670 SHG
¥16.56-¥0.55  (3.21%)
Estimate
EPS
-1.54
Beta
0.281
Growth
Revenue, YoY
-79.94%
Net income, YoY
-29.95%
FCF, YoY
84.45%
About the company
Ticker
688670
ISIN
CNE100004NR4
Country
China
Sector (GICS)
Healthcare
Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. It offers quadrivalent influenza virus split vaccines. The company human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. Jiangsu Gdk Biological Technology Co., Ltd was founded in 2008 and is based in Taizhou, China.

Frequently asked questions

What sector does Jiangsu GDK Biotechnology Co Ltd (688670) operate in?

Jiangsu GDK Biotechnology Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Jiangsu GDK Biotechnology Co Ltd (688670) current stock price?

As of the latest data, Jiangsu GDK Biotechnology Co Ltd stock price is CN¥16.56, with a previous close of CN¥17.11. Jiangsu GDK Biotechnology Co Ltd lost -CN¥0.55 in the last trading session, representing a -3.21% loss.

What is Jiangsu GDK Biotechnology Co Ltd (688670) current market capitalization?

Jiangsu GDK Biotechnology Co Ltd market cap is approximately 2.04 billion.

What is Jiangsu GDK Biotechnology Co Ltd (688670) Earnings Per Share (EPS)?

The trailing EPS is -CN¥1.54.

Does Jiangsu GDK Biotechnology Co Ltd (688670) pay dividends?

No. Jiangsu GDK Biotechnology Co Ltd does not pay a dividend.

What is Jiangsu GDK Biotechnology Co Ltd (688670) beta (volatility) score?

Jiangsu GDK Biotechnology Co Ltd has a beta of 0.281, indicating lower volatility than the overall market.